Senators question FDA policy on advisory panels

A group of senators asked the Government Accountability Office to review the FDA's policy of allowing medical experts with financial ties to drug and medical-device manufacturers to serve on FDA advisory panels. The practice of granting waivers for such experts appears to have "undermined the public's faith in the objectivity and fairness of FDA's advisory committees," the senators said.

View Full Article in: (Hackensack, N.J.) (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT